Usefulness of Dobutamine-Induced Changes of the Two-Dimensional Longitudinal Deformation Predict Clinical and Neurohumoral Improvement in Men After Levosimendan Treatment in Acutely Decompensated Chronic Heart Failure

American Journal of Cardiology

Volumn 102, Issue 9, 2008, Pages 1225-1229

  Paraskevaidis, Ioannis A ^a   Bistola, Vassiliki ^a   Ikonomidis, Ignatios ^a   Parissis, John T ^a   Papadopoulos, Constantinos ^a   Filippatos, Gerasimos ^a   Kremastinos, Dimitrios T ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DOBUTAMINE; LEVOSIMENDAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HUMAN; LOW DRUG DOSE; MALE; PREDICTION; PRIORITY JOURNAL; STRESS ECHOCARDIOGRAPHY;

AGED; CARDIOTONIC AGENTS; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; HYDRAZONES; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PYRIDAZINES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME;

EID: 54549084511     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.06.060     Document Type: Article

References (16)

1. Moiseyev V.S., Poder P., Andrejevs N., Ruda M.Y., Golikov A.P., Lazebnik L.B., Kobalava Z.D., Lehtonen L.A., Laine T., Nieminen M.S., and Lie K.I. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J 23 (2002) 1422-1432
2. Follath F., Cleland J.G., Just H., Papp J.G., Scholz H., Peuhkurinen K., Harjola V.P., Mitrovic V., Abdalla M., Sandell E.P., and Lehtonen L. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomized double-blind trial. Lancet 360 (2002) 196-202
3. Mebazaa A., Nieminen M.S., Packer M., Cohen-Solal A., Kleber F.X., Pocock S.J., Thakkar R., Padley R.J., Poder P., and Kivikko M. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial. JAMA 297 (2007) 1883-1891
4. Nieminen M.S., Böhm M., Cowie M.R., Drexler H., Filippatos G.S., Jondeau G., Hasin Y., Lopez-Sendon J., Mebazaa A., Metra M., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 384-416
5. Slawsky M.T., Colucci W.S., Gottlieb S.S., Greenberg B.H., Haeusslein E., Hare J., Hutchins S., Leier C.V., LeJemtel T.H., Loh E., et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Circulation 102 (2000) 2222-2227
6. Paraskevaidis I.A., Adamopoulos S., and Kremastinos D.T. Dobutamine echocardiographic study in patients with nonischemic dilated cardiomyopathy and prognostically borderline values of peak exercise oxygen consumption: 18-month follow-up study. J Am Coll Cardiol 37 (2001) 1685-1691
7. Cheitlin M.D., Armstrong W.F., Aurigemma G.P., Beller G.A., Bierman F.Z., Davis J.L., Douglas P.S., Faxon D.P., Gillam L.D., Kimball T.R., et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol 42 (2003) 954-970
8. Seghatol F.F., Shah D.J., Diluzio S., Bello D., Johnson M.R., Cotts W.G., O'Donohue J.A., Bonow R.O., Gheorghiade M., and Rigolin V.H. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 93 (2004) 854-859
9. Perk G., Tunick P.A., and Kronzon I. Non-Doppler two-dimensional strain imaging by echocardiography-from technical considerations to clinical applications. J Am Soc Echocardiogr 20 (2007) 234-243
10. Quere J.P., Monin J.L., Levy F., Petit H., Baleynaud S., Chauvel C., Pop C., Ohlmann P., Lelguen C., Dehant P., et al. Influence of preoperative left ventricular contractile reserve on postoperative ejection fraction in low-gradient aortic stenosis. Circulation 113 (2006) 1738-1744
11. Hanekom L., Jenkins C., Jeffries L., Case C., Mundy J., Hawley C., and Marwick T.H. Incremental value of strain rate analysis as an adjunct to wall-motion scoring for assessment of myocardial viability by dobutamine echocardiography: a follow-up study after revascularization. Circulation 112 (2005) 3892-3900
12. Hoffmann R., Altiok E., Nowak B., Kuhl H., Kaiser H.J., Buell U., and Hanrath P. Strain rate analysis allows detection of differences in diastolic function between viable and nonviable myocardial segments. J Am Soc Echocardiogr 18 (2005) 330-335
13. Leitman M., Lysyansky P., Sidenko S., Shir V., Peleg E., Binenbaum M., Kaluski E., Krakover R., and Vered Z. Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr 17 (2004) 1021-1029
14. Serri K., Reant P., Lafitte M., Berhouet M., Le Bouffos V., Roudaut R., and Lafitte S. Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. J Am Coll Cardiol 47 (2006) 1175-1181
15. Sengupta P.P., Krishnamoorthy V.K., Korinek J., Narula J., Vannan M.A., Lester S.J., Tajik J.A., Seward J.B., Khandheria B.K., and Belohlavek M. Left ventricular form and function revisited: applied translational science to cardiovascular ultrasound imaging. J Am Soc Echocardiogr 20 (2007) 539-551
16. Otasevic P., Popovic Z.B., Vasiljevic J.D., Pratali L., Vlahovic-Stipac A., Boskovic S.D., Tasic N., and Neskovic A.N. Head-to-head comparison of indices of left ventricular contractile reserve assessed by high-dose dobutamine stress echocardiography in idiopathic dilated cardiomyopathy: five-year follow up. Heart 92 (2006) 1253-1258